Arbutus Biopharma Corp operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Arbutus Biopharma Corp with three other companies in this sector in CANADA : Antibe Therapeutics Inc (2020 sales of 9.99 million Canadian Dollars [US$7.87 million] ), Medicure Inc (11.61 million Canadian Dollars [US$9.15 million] of which 100% was Pharmaceutical Prod), and Microbix Biosystems Inc (10.52 million Canadian Dollars [US$8.29 million] of which 100% was Antigen Products and Technologies).

Sales Analysis. During the second quarter of 2021, sales at Arbutus Biopharma Corp totalled C$2.85 million. This is an increase of 36.9% from the C$2.08 million in sales at the company during the second quarter of 2020. During the first two quarters of 2021, sales totalled C$5.53 million, which is 34.8% higher than through the first two quarters of 2020. During the year ended December of 2020, sales at Arbutus Biopharma Corp were C$9.26 million (US$7.30 million). This is an increase of 16.4% versus 2019, when the company's sales were C$7.95 million.